Overview: TORCH DNA Detection TestIntroduction: The TORCH DNA Detection Test detects TORCH pathogens DNA to diagnose congenital infections, causing birth defects. Following 2023 ACOG guidelines, it uses PCR for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for pregnant women or newborns with suspected congenital infections.
Other Names: TORCH PCR Assay, Congenital Infection DNA Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: TORCH testing began in the 1970s with congenital infection research. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects TORCH pathogens DNA to diagnose congenital infections, guides treatment, and evaluates birth defect risks.
Test Parameters: 1. TORCH Pathogen DNA
Pretest Condition: No fasting required. Collect whole blood, serum, plasma, CSF, or saliva. Report history of birth defects or maternal infections.
Specimen: Whole Blood (EDTA, 2-5 mL), Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL), CSF (sterile container, 1-2 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document birth defects, maternal infections, or history of TORCH infections. Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, congenital infection implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect DNA of TORCH pathogens (Toxoplasma, Rubella, CMV, HSV). Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for congenital infection diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or contamination can affect results. Sample quality impacts specificity.
Clinical Significance: Positive TORCH DNA confirms congenital infection, guiding antiviral or supportive therapy. Negative results may require serology or culture.
Specialist Consultation: Consult an infectious disease specialist or neonatologist for result interpretation and treatment planning.
Additional Supporting Tests: TORCH serology, viral culture, or fetal ultrasound to confirm congenital infection diagnosis.
Test Limitations: Specific to detectable pathogens; clinical correlation is needed. Sample quality affects sensitivity.
References: ACOG Congenital Infection Guidelines, 2023; Clinical Infectious Diseases, Maldonado YA, 2022.
